- According to Transparency Market Research’s latest report on the global hemostasis and tissue sealing agents market for the historical period 2017–2018 and forecast period 2019–2027, rise in demand for minimally invasive procedures and increase in global geriatric population are projected to drive the global hemostasis and tissue sealing agents market during the forecast period
- According to the report, the global hemostasis and tissue sealing agents market was valued at US$ 5.1 Bn in 2018 and is anticipated to expand at a CAGR of 8.3% from 2019 to 2027
Request a sample to get extensive insights into the Automotive Heat Shield Market
Rise in demand for minimally invasive procedures: Key Drivers
- The preference for minimally invasive surgeries has increased significantly in the past few years. Minimally invasive surgeries have advantages such as shorter hospital stay, minimal incision, fewer post-surgical complications and shorter recovery time. Systemic hemostatic agents such as gelatin and collagen-based hemostat powders are widely used in minimally invasive procedures. These agents enable surgeons to perform complex surgeries.
- According to a study conducted by the World Health Organization (WHO), approximately 234.2 million major surgical procedures are undertaken by various hospitals and surgical centers across the world each year. Thus, rising number of surgical procedures and growing preference for minimally invasive procedures boosts the demand of hemostat and tissue sealing agents.
To understand how our report can bring difference to your business strategy, Ask for a brochure
Aging population increases the number of surgeries needing hemostat products boost market growth
- Treatment services have become affordable due to improvement in health care policies in countries such as the U.S., Japan, the U.K. and China. This, in turn, has increased the life expectancy of the population. Consequently, rise in the geriatric population increases the number of surgical procedures that use adhesion barrier and hemostat products. According to the U.S. Department of Health & Human Product estimates, the U.S. will have about 72.1 Mn geriatric population by 2030, which is more than twice the number in 2000.
- The UN Population Division has projected that the number of people aged 60 years and above will increase significantly during 2015–2030. In developed countries, the total proportion of people aged 60 years and above has increased from 12% in 1950 to 22% in 2011 and is expected to reach 32% by 2050. Thus, the aging population drives the uptake of hemostat, tissue sealant and adhesion barrier products and boosts market growth.
High cost and strict regulatory requirement to Hamper Market
- Hemostat and tissue sealant products development is a complex and expensive process. Regulatory approval of hemostat products demands valid scientific evidences, well controlled investigations and documented case studies. Despite high expense incurred for the development of hemostat products by manufacturers, the success rate of the approval of these products by regulatory bodies is low. Low efficacy and safety of the products have been attributed to the low approval rate of hemostat products. Only a small number of companies have entered the market due to setbacks faced in clinical studies by hemostat manufacturers. This hampers the growth of the hemostasis and tissue sealing agents market.
Global Hemostasis and tissue sealing agents Market: Competitive Landscape
- This report profiles major players in the global hemostasis and tissue sealing agents market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments
- The global Hemostasis and tissue sealing agents market is highly fragmented, with the presence of a number of international as well as regional players
- Leading players operating in the global Hemostasis and tissue sealing agents market are
- Advanced Medical Solutions Group plc
- Baxter
- Cohera Medical, Inc.
- CryoLife, Inc.
- C.R. Bard, Inc.
- Johnson & Johnson Services, Inc.
- Integra LifeSciences Corporation
- Pfizer, Inc.
- Cohesion Technologies Inc.
- B Braun Medical Inc
- other prominent players.
Stuck in a neck-to-neck competition with other brands? Request a custom report on Hemostasis and Tissue Sealing Agents Market
Global Hemostasis and Tissue Sealing Agents Market: Key Developments
Key players in the global hemostasis and tissue sealing agents market are engaged in regulatory approvals, technologically advanced products, launch of new products, and acquisition & collaborative agreements with other companies. These strategies are likely to fuel the growth of the global hemostasis and tissue sealing agents market. A few expansion strategies adopted by players operating in the global Hemostasis and tissue sealing agents market are:
- In July 2020, Sysmex Corporation launched new product in the hemostasis field i.e. Automated Blood Coagulation Analyzers, which is used for chemiluminescence enzyme immunoassay to enhance testing workflow efficiency
- In January 26, 2020, Terumo Corporation launched new surgical sealant product i.e. AQUABRID in EMEA Market. This product helps to stop bleeding during aortic surgical procedures.
- In January 2018, Baxter acquired two hemostat and sealant products i.e. RECOTHROM and PREVELEAK from Mallinckrodt plc for broaden portfolio of innovative surgical products.
The report on the global hemostasis and tissue sealing agents market discussed individual strategies, followed by company profiles of manufacturers of hemostasis and tissue sealing agents. The competitive landscape section has been included in the report to provide readers with a dashboard view and a company market share analysis of key players operating in the global hemostasis and tissue sealing agents market.
Global Hemostasis and Tissue Sealing Agents Market – Segmentation
|
Type |
|
|
Region |
|
Frequently Asked Questions
What is the total market worth of hemostasis and tissue sealing agents market?
Hemostasis and tissue sealing agents market to reach the valuation of US$ 10.3 Bn by 2027
What is the anticipated CAGR of the hemostasis and tissue sealing agents market in the forecast period?
Hemostasis and tissue sealing agents market is anticipated to expand at a CAGR of 8.3% from 2019 to 2027
What are the key driving factors for the growth of the hemostasis and tissue sealing agents market?
Hemostasis and tissue sealing agents market is driven by rise in demand for minimally invasive procedures and increase in global geriatric population
Which region is expected to project the highest market share in the global hemostasis and tissue sealing agents market?
North America held the largest share of the global hemostasis and tissue sealing agents market
Who are the key players in the global hemostasis and tissue sealing agents market?
Key players in the hemostasis tissue sealing agents market include Advanced Medical Solutions Group PLC, Cohera Medical, Inc., C. R. Bard, Inc., Integra Life Sciences Corporation, Cohesion Technologies Inc.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Hemostasis and Tissue Sealing Agents Market
4. Market Overview
4.1. Introduction
4.1.1. Type Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Hemostasis and Tissue Sealing Agents Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Key Development in the Market
5.2. Mergers & Acquisitions
5.3. COVID-19 Impact Analysis
6. Global Hemostasis and Tissue Sealing Agents Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.1.1. Key Findings / Developments
6.2. Global Hemostasis and Tissue Sealing Agents Market Value Forecast, by Type, 2017–2027
6.2.1. Topical Hemostat
6.2.1.1. Mechanical Hemostats
6.2.1.1.1. Collagen based Topical Hemostats
6.2.1.1.2. ORC based Topical Hemostats
6.2.1.1.3. Gelatin based Topical Hemostats
6.2.1.1.4. Polysaccharide based Topical Hemostats
6.2.1.2. Active Hemostats
6.2.1.3. Flowable Hemostats
6.2.2. Adhesive and Tissue Sealing Agents
6.2.2.1. Natural Tissue Sealant
6.2.2.2. Synthetic Tissue Sealant
6.2.2.3. Adhesion Barrier Products
6.3. Global Hemostasis and Tissue Sealing Agents Market Analysis, by Type
6.4. Global Hemostasis and Tissue Sealing Agents Market Attractiveness, by Type
7. Global Hemostasis and Tissue Sealing Agents Market Analysis and Forecast, by Region
7.1. Key Findings
7.2. Global Hemostasis and Tissue Sealing Agents Market Value Forecast, by Region
7.2.1. North America
7.2.2. Europe
7.2.3. Asia Pacific
7.2.4. Latin America
7.2.5. Middle East & Africa
7.3. North America Hemostasis and Tissue Sealing Agents Market Attractiveness, by Region
8. North America Hemostasis and Tissue Sealing Agents Market Analysis and Forecast
8.1. Introduction
8.1.1. Key Findings
8.2. North America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027
8.2.1. Topical Hemostat
8.2.1.1. Mechanical Hemostats
8.2.1.1.1. Collagen based Topical Hemostats
8.2.1.1.2. ORC based Topical Hemostats
8.2.1.1.3. Gelatin based Topical Hemostats
8.2.1.1.4. Polysaccharide based Topical Hemostats
8.2.1.2. Active Hemostats
8.2.1.3. Flowable Hemostats
8.2.2. Adhesive and Tissue Sealing Agents
8.2.2.1. Natural Tissue Sealant
8.2.2.2. Synthetic Tissue Sealant
8.2.2.3. Adhesion Barrier Products
8.3. North America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country, 2017–2027
8.3.1. U.S.
8.3.2. Canada
8.4. North America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis
8.4.1. By Type
8.4.2. By Country
9. Europe Hemostasis and Tissue Sealing Agents Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Europe Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027
9.2.1. Topical Hemostat
9.2.1.1. Mechanical Hemostats
9.2.1.1.1. Collagen based Topical Hemostats
9.2.1.1.2. ORC based Topical Hemostats
9.2.1.1.3. Gelatin based Topical Hemostats
9.2.1.1.4. Polysaccharide based Topical Hemostats
9.2.1.2. Active Hemostats
9.2.1.3. Flowable Hemostats
9.2.2. Adhesive and Tissue Sealing Agents
9.2.2.1. Natural Tissue Sealant
9.2.2.2. Synthetic Tissue Sealant
9.2.2.3. Adhesion Barrier Products
9.3. Europe Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
9.3.1. Germany
9.3.2. U.K.
9.3.3. France
9.3.4. Spain
9.3.5. Italy
9.3.6. Rest of Europe
9.4. Europe Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis
9.4.1. By Type
9.4.2. By Country/Sub-region
10. Asia Pacific Hemostasis and Tissue Sealing Agents Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Asia Pacific Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027
10.2.1. Topical Hemostat
10.2.1.1. Mechanical Hemostats
10.2.1.1.1. Collagen based Topical Hemostats
10.2.1.1.2. ORC based Topical Hemostats
10.2.1.1.3. Gelatin based Topical Hemostats
10.2.1.1.4. Polysaccharide based Topical Hemostats
10.2.1.2. Active Hemostats
10.2.1.3. Flowable Hemostats
10.2.2. Adhesive and Tissue Sealing Agents
10.2.2.1. Natural Tissue Sealant
10.2.2.2. Synthetic Tissue Sealant
10.2.2.3. Adhesion Barrier Products
10.3. Asia Pacific Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
10.3.1. China
10.3.2. Japan
10.3.3. India
10.3.4. Australia & New Zealand
10.3.5. Rest of Asia Pacific
10.4. Asia Pacific Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis
10.4.1. By Type
10.4.2. By Country/Sub-region
11. Latin America Hemostasis and Tissue Sealing Agents Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Latin America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027
11.2.1. Topical Hemostat
11.2.1.1. Mechanical Hemostats
11.2.1.1.1. Collagen based Topical Hemostats
11.2.1.1.2. ORC based Topical Hemostats
11.2.1.1.3. Gelatin based Topical Hemostats
11.2.1.1.4. Polysaccharide based Topical Hemostats
11.2.1.2. Active Hemostats
11.2.1.3. Flowable Hemostats
11.2.2. Adhesive and Tissue Sealing Agents
11.2.2.1. Natural Tissue Sealant
11.2.2.2. Synthetic Tissue Sealant
11.2.2.3. Adhesion Barrier Products
11.3. Latin America Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
11.3.1. Brazil
11.3.2. Mexico
11.3.3. Rest of Latin America Latin America
11.4. Latin America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis
11.4.1. By Type
11.4.2. By Country/Sub-region
12. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Application, 2017–2027
12.2.1. Topical Hemostat
12.2.1.1. Mechanical Hemostats
12.2.1.1.1. Collagen based Topical Hemostats
12.2.1.1.2. ORC based Topical Hemostats
12.2.1.1.3. Gelatin based Topical Hemostats
12.2.1.1.4. Polysaccharide based Topical Hemostats
12.2.1.2. Active Hemostats
12.2.1.3. Flowable Hemostats
12.2.2. Adhesive and Tissue Sealing Agents
12.2.2.1. Natural Tissue Sealant
12.2.2.2. Synthetic Tissue Sealant
12.2.2.3. Adhesion Barrier Products
12.3. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
12.3.1. GCC Countries
12.3.2. South Africa
12.3.3. Rest of Middle East & Africa
12.4. Middle East & Africa Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis
12.4.1. By Application
12.4.2. By Country/Sub-region
13. Competition Landscape
13.1. Market Player - Competition Matrix (by Tier and Size of companies)
13.2. Market Share / Position Analysis, by Company, 2019
13.3. Company Profiles
13.3.1. Advanced Medical Solutions Group plc
13.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.1.2. Financial Analysis
13.3.1.3. Growth Strategies
13.3.1.4. SWOT Analysis
13.3.2. Baxter
13.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.2.2. Financial Analysis
13.3.2.3. Growth Strategies
13.3.2.4. SWOT Analysis
13.3.3. Cohera Medical, Inc .
13.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.3.2. Financial Analysis
13.3.3.3. Growth Strategies
13.3.3.4. SWOT Analysis
13.3.4. CryoLife, Inc .
13.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.4.2. Financial Analysis
13.3.4.3. Growth Strategies
13.3.4.4. SWOT Analysis
13.3.5. C.R. Bard, Inc
13.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.5.2. Financial Analysis
13.3.5.3. Growth Strategies
13.3.5.4. SWOT Analysis
13.3.6. Johnson & Johnson Services, Inc
13.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.6.2. Financial Analysis
13.3.6.3. Growth Strategies
13.3.6.4. SWOT Analysis
13.3.7. Integra LifeSciences Corporation.
13.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.7.2. Financial Analysis
13.3.7.3. Growth Strategies
13.3.7.4. SWOT Analysis
13.3.8. Pfizer, Inc.
13.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.8.2. Financial Analysis
13.3.8.3. Growth Strategies
13.3.8.4. SWOT Analysis
13.3.9. Cohesion Technologies Inc.
13.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.9.2. Financial Analysis
13.3.9.3. Growth Strategies
13.3.9.4. SWOT Analysis
13.3.10. B Braun Medical Inc.
13.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
13.3.10.2. Financial Analysis
13.3.10.3. Growth Strategies
13.3.10.4. SWOT Analysis
13.3.11. Other prominent Players
List of Table
Table 01: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017–2027
Table 02: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027
Table 03: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027
Table 04: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027
Table 05: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Region, 2017–2027
Table 06: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017-2027
Table 07: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027
Table 08: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027
Table 09: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027
Table 10: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Country, 2017-2027
Table 11: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017-2027
Table 12: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027
Table 13: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027
Table 14: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027
Table 15: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
Table 16: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017-2027
Table 17: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027
Table 18: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027
Table 19: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027
Table 20: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
Table 21: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017-2027
Table 22: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027
Table 23: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027
Table 24: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027
Table 25: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
Table 26: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Type, 2017-2027
Table 27: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Topical Hemostat, 2017–2027
Table 28: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Mechanical Hemostats, 2017–2027
Table 29: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Adhesive and Tissue Sealing Agents, 2017–2027
Table 30: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, by Country/Sub-region, 2017-2027
List of Figure
Figure 01: Global Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, 2019–2027
Figure 02: Market Value Share, by Type (2018)
Figure 04: Market Value Share, by Region (2018)
Figure 05: Global Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Type, 2018 and 2027
Figure 06: Global Hemostasis and Tissue Sealing Agents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Topical Hemostat, 2017–2027
Figure 07: Global Hemostasis and Tissue Sealing Agents Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Adhesive and Tissue Sealing Agents, 2017–2027
Figure 08: Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Type, 2019-2027
Figure 09: Global Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Region, 2018 and 2027
Figure 10: Global Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Region 2019-2027
Figure 11: North America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, 2017–2027
Figure 12: North America Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Type, 2018 and 2027
Figure 13: North America Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Country, 2018 and 2027
Figure 14: North America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Type, 2019–2027
Figure 15: North America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Country, 2019-2027
Figure 16: Europe Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 17: Europe Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Type, 2018 and 2027
Figure 18: Europe Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 19: Europe Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Type, 2019-2027
Figure 20: Europe Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
Figure 21: Asia Pacific Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 22: Asia Pacific Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Type, 2018 and 2027
Figure 23: Asia Pacific Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 24: Asia Pacific Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Type, 2019-2027
Figure 25: Asia Pacific Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
Figure 26: Latin America Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast, 2017–2027
Figure 27: Latin America Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Type, 2018 and 2027
Figure 28: Latin America Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Country, 2018 and 2027
Figure 29: Latin America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Type, 2019–2027
Figure 30: Latin America Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Country, 2019-2027
Figure 31: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 32: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Type, 2018 and 2027
Figure 33: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 34: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Type, 2019-2027
Figure 35: Middle East & Africa Hemostasis and Tissue Sealing Agents Market Attractiveness Analysis, by Country/Sub-region, 2019-2027
Figure 36: Global Hemostasis and Tissue Sealing Agents Market Share Analysis, by Company (2019)
